Helping patients across multiple diseasesRevenue split by therapeutic areas1
Servicing a diversified customer baseRevenue split by customer type1
Solutions along the value chainRevenue split by business segment and number of active custom projects by stage of development1
1Approximate splits as per 31 December 2021.
Business model Providing expert knowledge for peptide-based API's across the entire value chain
API – Active Pharmaceutical Ingredient; CMC – Chemistry, Manufacuring & Controls; GMP – Good Manufacturing Practice; ICH – International Council for Harmonization; LCM – Life Cycle Management; NDA – New Drug Application; PPQ – Process Performance Qualification.
Integrated strategyStriving to be the preferred long-term partner for customers
Footprint and customer proximityExperienced team1 and GMP-certified manufacturing network
1Data based on headcount as of 31 December 2021.
Striving for profitable growthBuilding on favorable market trends
1For a reconcilliation to the nearest IFRS line item, please refer to the section “Definitions and reconciliations” of this report.